Search

Search Constraints

You searched for: Author/Creator Saliba, Rima M.

Search Results

1. Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era. (6th April 2021)

2. Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission. Issue 18 (17th June 2013)

3. Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission. Issue 18 (17th June 2013)

4. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning. Issue 14 (21st March 2017)

5. Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant. Issue 3 (10th March 2023)

6. Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome. Issue 10 (20th January 2021)

7. Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation. Issue 12 (21st October 2019)

8. Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease. (November 2017)

9. Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. Issue 10 (3rd September 2016)

10. Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high‐dose chemotherapy and autologous stem cell transplantation for lymphoma. Issue 4 (10th February 2017)